Gary S. Gordon, MD | Authors

Articles

Chemoradiation for Locally Advanced, Unresectable NSCLC

August 01, 1999

The optimal therapy for locally advanced, unresectable, stage III non–small-cell lung cancer (NSCLC) continues to evolve. The critical determinants of overall survival include local tumor control and the